Want to see INSM full AI Analyst Report?
Total Valuation
Insmed has a market cap or net worth of $24.19B. The enterprise value is $21.51B.
Market Cap$24.19B
Enterprise Value$21.51B
Share Statistics
Insmed has 216,752,460 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding216,752,460
Owned by Insiders0.72%
Owned by Institutions<0.01%
Financial Efficiency
Insmed’s return on equity (ROE) is -1.73 and return on invested capital (ROIC) is -64.84%.
Return on Equity (ROE)-1.73
Return on Assets (ROA)-0.56
Return on Invested Capital (ROIC)-64.84%
Return on Capital Employed (ROCE)-0.66
Revenue Per Employee477.12K
Profits Per Employee-1.00M
Employee Count1,271
Asset Turnover0.27
Inventory Turnover0.95
Valuation Ratios
The current PE Ratio of Insmed is ―. Insmed’s PEG ratio is -1.80.
PE Ratio―
PS Ratio61.31
PB Ratio50.31
Price to Fair Value50.31
Price to FCF-38.43
Price to Operating Cash Flow-26.85
PEG Ratio-1.80
Income Statement
In the last 12 months, Insmed had revenue of 606.42M and earned -1.28B in profits. Earnings per share was -6.41.
Revenue606.42M
Gross Profit481.55M
Operating Income-1.18B
Pretax Income-1.27B
Net Income-1.28B
EBITDA-1.17B
Earnings Per Share (EPS)-6.41
Cash Flow
In the last 12 months, operating cash flow was -895.66M and capital expenditures -55.97M, giving a free cash flow of -951.63M billion.
Operating Cash Flow-895.66M
Free Cash Flow-951.63M
Free Cash Flow per Share-4.39
Dividends & Yields
Insmed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.76
52-Week Price Change14.11%
50-Day Moving Average111.50
200-Day Moving Average151.76
Relative Strength Index (RSI)59.41
Average Volume (3m)5.24M
Important Dates
Insmed upcoming earnings date is Jul 30, 2026, TBA (Confirmed).
Last Earnings DateMay 7, 2026
Next Earnings DateJul 30, 2026
Ex-Dividend Date―
Financial Position
Insmed as a current ratio of 3.83, with Debt / Equity ratio of 106.18%
Current Ratio3.83
Quick Ratio3.54
Debt to Market Cap0.02
Net Debt to EBITDA-0.22
Interest Coverage Ratio-14.04
Taxes
In the past 12 months, Insmed has paid 5.03M in taxes.
Income Tax5.03M
Effective Tax Rate>-0.01
Enterprise Valuation
Insmed EV to EBITDA ratio is -31.96, with an EV/FCF ratio of -38.69.
EV to Sales61.74
EV to EBITDA-31.96
EV to Free Cash Flow-38.69
EV to Operating Cash Flow-40.04
Balance Sheet
Insmed has $1.22B in cash and marketable securities with $748.43M in debt, giving a net cash position of $475.08M billion.
Cash & Marketable Securities$1.22B
Total Debt$748.43M
Net Cash$475.08M
Net Cash Per Share$2.19
Tangible Book Value Per Share$2.36
Margins
Gross margin is 81.56%, with operating margin of -194.04%, and net profit margin of -210.54%.
Gross Margin81.56%
Operating Margin-194.04%
Pretax Margin-209.71%
Net Profit Margin-210.54%
EBITDA Margin-193.18%
EBIT Margin-195.90%
Analyst Forecast
The average price target for Insmed is $199.89, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$199.89
Price Target Upside38.35% Upside
Analyst ConsensusStrong Buy
Analyst Count19
Revenue Growth Forecast115.09%
EPS Growth Forecast3.42%